Listeria monocytogenes (Bast et al., 1975) or protozoa such as Toxoplasma gondii (Hibbs et al., 1971) or Besnoitia jellisoni (Lunde and Gelderman, 1971) , has been shown to be associated with a state of resistance to tumours. The long persistence of the organisms in the body has seemed to prolong the antitumour effect (Hibbs et al., 1971) . Antibody production (Stjernsward, 1966) and cell-mediated immunity (Miller et al., 1973) , were also stimulated by those infections. However, positive results have not always been obtained, and infections have been shown to depress both the immune response and resistance to tumour grafts (Piessens et al., 1970) . But, in all instances, the activation of several macrophage functions was noted (Greenwood et al., 1971a, b) . Dead organisms like Corynebacterium parvum (Woodruff and Boak, 1966) and Bordetella pertussis (Likhite, 1974) have also been found to enhance macrophage functions and antitumour responses.
Brucella abortus (BA) is an intracellular parasite mainly of cattle, but, in certain farming communities, has been shown to infect man on a very large scale, usually without clinical disease (Zourbas et al., 1977) . In addition, in Russia an extensive programme of human vaccination with live Brucella has been undertaken using the strain 19 BA-itself derived from the Accepte(d 19 Juine 1978 strain B19 of Cotton et al. (1933) As shown in Fig. a , after injecting 5x 102 organisms, the number of bacteria in the lymphoid organs increased until the third week. By contrast, in the infection provoked by 5 x 106 organisms, the maximal number of bacteria was found as early as the first week. Whatever the amount of Brucella injected, the infection subsided within 6 weeks.
The spleen and liver enlarged during the infection. Their increase in weight roughly paralleled their content of live Brucella organisms, but a delay of 1 or 2 weeks between the 2 curves could be noticed (Fig. b) . The maximal hypertrophy was reached on the fourth week after infection with 5 x 102 Brucella and on the second or third week after 5 x 106. The infection was more florid after the introduction of 5 x 106 organisms.
The prolongation of survival time of the lymphoma-bearing mice was significantly but slightly increased from the third to the 5th week in the mice infected with 5 x 102 organisms (Fig. c) . The infection by 5 x 106 organisms provoked a longer survival, particularly during the first and second week after inoculation of the vaccine.
On the whole, it seemed that the resistance to lymphoma was better correlated with the number of infectious organisms than with the degree of hyperplasia of liver and spleen. This observation raises the question of the role of the organisms themselves in the antitumour defence process. Veskova et al. (1974) suggested the possibility of the secretion by Brucella of substances inhibiting cell division. Alternatively, immunological defence mechanisms directed against Brucella could act against cancer cells. Brucella infection is, 465 -v however, known to enhance the resistance against other intracellular organisms nonspecifically (Mackaness, 1964) an effect probably mediated by macrophages. Macrophages activated by Brucella infection could also play a non-specific role in the control of lymphoma growth.
Comparing the present results with those previously obtained with dead Brucella (Toujas et al., 1972a, b) it will be noticed that higher numbers of killed organisms were required: 22 x 109 (500 pg dry weight) as against 5 x 102 or 5 x 106 live organisms in the present work. The hyperplasia of the lymphoid organs produced by dead Brucella, mainly associated with proliferation of marrow-derived cells (Toujas et al., 1972a) was maximal on the tenth day after bacterial injection and correlated with a diminution of antibody response against sheep-red-blood-cell antigens. An antileukaemic effect appeared 40 days after the initial infection (Toujas et al., 1972b) .
The use of a live vaccinal strain of B. abortu8 may be interesting to consider for possible application in man. The pathogenicity for man of the strain B1 9 has been pointed out by several authors (see Goret and Pilet, 1962; Roux, 1972) . Acute brucellosis in veterinary surgeons has been shown to result from accidental contamination during the vaccination of cattle. The live Brucella vaccine prepared in U.S.S.R. from strain 19BA has been used on a large scale in humans. More than 3 million individuals received an s.c. inoculation of 3 to 6 x 108 organisms. Few important side effects were recorded: local swelling at the site of injection, general malaise and headache in 8% of cases. Marked reactions occurred in persons who had suffered brucellosis in the past (Vershilova, 1961). For Spink et al. (1962) the inocuousness of strain 19 BA was found to be very disputable. In a trial with 16 volunteers, receiving an s.c. injection of 2-5X108 organisms, 2 disseminated brucellosis cases were found. The application of the vaccine by scarification (2 x 109 organisms per dose) as described by Zenkova (1956) , could be tolerated better.
Perhaps quantities smaller than those used by the authors cited above would be sufficient to induce a non-specific stimulation. In the present work doses of 5 x 102 were found to be effective in the mouse. However, the use of live Brucella as an adjuvant treatment of cancer in man should be accepted with caution, and in any case requires further experimental support.
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